Medicare’s $2,100 Drug Quietly Reshapes Prescription Costs for Investors
Medicare's out-of-pocket cap for covered prescriptions rises to $2,100 in 2026, ending the donut-hole-era for many pa...
Vix Vs Daily Index Volatility Readings
VIX and daily volatility offer complementary views of risk. This overview explains how to interpret both for better timing and sizing.
21,383 articles
U.S. Military Expert Issues Grim Warning on Munitions Delays
A leading defense analyst warns of a readiness gap as U.S. munitions deliveries lag demand, signaling a multiyear bud...
Bernie Sanders Elon Musk Tax Plan Could Save Social Security
Social Security's finances are under pressure as 2033 insolvency looms and a $26.1 trillion 75-year shortfall exists....
Iran Moves to Charge Insurance Fees in Hormuz Toll Bid
Iran asserts a new permission and insurance framework for crossing the Strait of Hormuz, while ships continue to move...
What Does Nayax President's Sale Mean for Investors?
A recent Insider Form 4 reveals Nayax Ltd.'s President sold 4,500 shares after exercising options. Here’s how to read...
SpaceX Pullback Signals Risk After Soaring IPO Debut
SpaceX stumbled after its blockbuster IPO, with shares drifting lower as investors weigh high growth bets in Starlink...
A Blood Test That Screens 50+ Cancers Moves Closer
A breakthrough blood test that screens for 50+ cancers is edging toward real-world use. This article breaks down what...
Boom Entering Phase NVIDIA: A New Wave of AI Winners
The AI boom is entering a new phase, moving beyond a single hardware star. This guide explores who stands to gain, ho...
Waymo Just Recalled 3,800 Robotaxis, Investor Debate Grows
Alphabet’s Waymo unit is under new scrutiny after a recall of 3,800 robotaxis. The move highlights scaling challenges...
Strategy Used $300 Million to Backstop Bitcoin Purchases
Strategy, formerly MicroStrategy, used $300 million to shore up liquidity while continuing to fund Bitcoin purchases....
Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Amazon Buy? Nearly Every Analyst Says Yes, Here’s Why
Amazon delivered strong AWS growth and solid Q1 results, but a large capex plan keeps investors wary. Still, a broad ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status